Abstract:
PURPOSE: A pharmaceutical composition containing thienopyrimidine derivative is provided to prevent or treating abnormal cell growth diseases. CONSTITUTION: A thienopyrimidine derivative is denoted by chemical formula 1. A method for preparing the derivative comprises: a step of reacting a compound of chemical formula 2 with formamide to prepare a compound of chemical formula 3; a step of substituting the compound of chemical formula 3 to prepare a compound of chemical formula 4; a step of coupling the compound of chemical formula 4 with a compound of chemical formula 5 to prepare a compound of chemical formula 1a. A pharmaceutical composition for preventing or treating abnormal cell growth diseases contains the derivative or pharmaceutically acceptable salt thereof as an active ingredient.
Abstract:
PURPOSE: A herbicide containing uracil compound as an active ingredient is provided to use as a non-selective herbicide which removes broad weeds. CONSTITUTION: A uracil compound is denoted by chemical formula 1. A herbicide contains the uracil compound of chemical formula 1, agriculturally acceptable salt or mixture thereof as an active ingredient. A herbicide composition contains 0.1-99.9 weight% of uracil compound of chemical formula 1, its agriculturally acceptable salt, or mixture thereof, and 0.1-99.9 weight% of additive of surfactant, or solid or liquid diluents. The composition is formulated in a form of suspension, emulsion, liquid, dispersion liquid, or tablet.
Abstract:
PURPOSE: A pharmaceutical composition containing pyridine derivative which is substituted with a novel benzoxazole is provided to ensure high effect to protein kinase in treating cell proliferation disorder. CONSTITUTION: A pyridine derivative which is substituted with a benzoxazole is denoted by the chemical formula 1. A method for preparing the derivative or its pharmaceutically acceptable salt comprises: a step of reacting a compound of the chemical formula 2 with a compound of the chemical formula 3 under the presence of metal; and a step of performing deprotection of a compound of the chemical formula 4.
Abstract:
본 발명은 광학활성 (R)-아릴옥시 프로피온산 에스터 유도체의 제조방법에 관한 것으로서, 보다 상세하게는 여러 관능기로 치환된 페놀 유도체와 (S)-알킬 O-아릴설포닐 락테이트를 반응물질로 사용하여 특정의 용매와 염기 및 온도조건에서 친핵치환 반응시켜 우수한 광학순도 및 생성수율로 다음 화학식 1로 표시되는 (R)-아릴옥시 프로피온산 에스터 유도체를 경제적으로 제조하는 방법에 관한 것이다. [화학식 1]
상기 화학식 1에서, R 1 및 A는 각각 발명의 상세한 설명에서 정의한 바와 같다. (S)-알킬 O-아릴설포닐 락테이트, (S)-에틸 Op-톨루엔설포닐 락테이트, (6-클로로-2-벤족사졸릴옥시)페닐, (6-클로로-2-벤즈티아졸릴옥시)페닐, (6-클로로퀴녹사졸릴옥시)페닐, 비극성 용매, 자일렌, 사이클로헥산, (R)-에틸 2-[4-(6-클로로벤족사졸릴옥시)펜옥시]프로피오네이트, 광학 활성
Abstract:
본 발명은 과수원 등의 비선택성 제초제로서 뿐만 아니라 옥수수, 콩과 같은 유용한 작물에는 약해를 주지 않으면서 소량의 처리로 화본과 및 광엽잡초를 선택적으로 방제할 수 있는 다음 화학식 1로 표시되는 신규 구조의 3,4,5,6-테트라히드로프탈이미드계 화합물과 이 화합물을 유효성분으로 함유하는 제초제에 관한 것이다.
상기 화학식 1에서, n, X 및 R은 각각 발명의 상세한 설명에서 정의된 바와 같다. 3,4,5,6-테트라히드로프탈이미드, 제초제, 화본과, 광엽잡초, 선택성
Abstract:
PURPOSE: Provided is a method for economically synthesizing glibenclamide, with powder shape, which is used as an intermediate for synthesis of medicine useful for treatment of diabetes. CONSTITUTION: The method comprises the steps of (i) reacting N-phenethyl-5-chloro-2-methoxybenzamide with chlorosulfonic acid(ClSO3H) represented by formula 2 in the presence of thionyl chloride(SOCl2) to form p-(N-phenethyl-5-chloro-2-methoxybenzamide)sulfonylchloride represented by formula 3; (ii) reacting sulfonylchloride compound represented by formula 3 with ammonia to form p-(N-phenethyl-5-chloro-2-methoxybenzamide)sulfoneamide represented by formula 4; (iii) reacting sulfoneamide compound represented by formula with alkali metal hydroxide in the presence of alcohol solvent to form p-(N-phenethyl-5-chloro-2-methoxybenzamide)sulfone amide-metal salt represented by formula 5; and (iv) reacting the metal represented by formula 5 with cyclohexyl isocyanate or phenylcyclohexyl carbamate to form glibenclamide represented by formula 1.
Abstract:
본 발명은 제초활성이 우수한 다음 화학식 1로 표시되는 페녹시프로피온 아미드 화합물과 벼농사에서 발생하는 피 방제하는 방법, 그리고 이들 화합물을 포함하는 제초제 조성물에 관한 것이다.
상기 화학식 1에서 : R은 수소원자, 또는 메틸기를 나타내고; X는 수소원자, 또는 플루오로원자를 나타내고; W는 술폰기(-SO 2 -), 카르보닐기(-CO-), 또는 (CH 2 ) n (이때 n은 0 또는 1의 정수임)을 나타내고; R 1 과 R 2 는 서로 같거나 다른 것으로서 수소원자, C 1 ∼C 6 의 알킬기, C 3 ∼C 6 의 싸이클로알킬기, C 1 ∼C 4 의 알콕시기, C 2 ∼C 6 의 알케닐기, 또는 C 2 ∼C 6 의 알키닐기를 나타낸다.
Abstract:
PURPOSE: A process for preparing alpha-ketocarboxylic acid derivatives by reacting alpha-hydroxycarboxylic acid derivatives with hypobromous acid(HOBr) is provided, which is industrially useful by using hypobromous acid in place of an oxidant that is expensive and harmful to environment. CONSTITUTION: The titled alpha-ketocarboxylic acid derivatives of formula 1 is prepared by reacting alpha-hydroxycarboxylic acid derivatives with hypobromous acid as an oxidant at -5 to 40deg.C, wherein the hypobromous acid is used in the range of 1 to 2 molar equivalent based on the compound of formula 2.
Abstract:
PURPOSE: A method for preparing carboxylic chloride compounds whose chloride is substituted from the lactone compound is provided, to improve the production yield with lowering the reaction temperature. CONSTITUTION: The method comprises the steps of reacting lactone compound and thionyl chloride in the presence of a Lewis acid and a quaternary ammonium salt at the atmospheric pressure and at 90-100 deg.C, wherein the addition amounts of the Lewis acid, the quaternary ammonium salt and thionyl chloride are 0.1-20 mol%, 0.1-20 mol% and 1-10 equivalence based on the amount of the lactone compound, respectively. Preferably the lactone compound is represented by the formula 2a or 2b, wherein R1, R2, R3 and R4 are H, a halogen atom, an alkyl group of C1-C4 or a haloalkyl group of C1-C4; R5 is H or an alkyl group of C1-C4; and n is an integer of 1-6. Preferably the Lewis acid is selected from MgCl2, MgBr2, SnCl2, SnCl4, TiCl4, AlCl3, FeCl3, BF3Et2O, BCl3, B(OEt)3, B(OMe)3 and B(O-iPr)3.
Abstract:
본 발명은 ο-(카르보알콕시)페닐메탄술포닐 클로라이드 유도체의 제조방법에 관한 것으로서, 더욱 상세하게는 ο-(클로로메틸)벤조산 에스테르로부터 중간체 화합물으로서 ο-(카르보알콕시)페닐메탄티오술폰산염을 합성한 다음, 염소화반응시켜 술포닐우레아 제초제 합성에 중요한 화합물인 다음 화학식 1로 표시되는 ο-(카르보알콕시)페닐메탄술포닐 클로라이드 유도체를 제조하는 새로운 방법에 관한 것이다. [화학식 1]
상기 화학식 1에서 : R 1 은 수소원자, 할로겐원자, 니트로기, C 1 ∼C 4 의 알킬기 또는 C 1 ∼C 4 의 할로알킬기를 나타내고; R 2 는 C 1 ∼C 6 의 알킬기 또는 C 3 ∼C 6 의 사이클로알킬기를 나타낸다.